Top Markets
#1 GEKKO GEKKO +51.79%
#2 ADO Protocol ADO Protocol +38.49%
#3 Helium Helium +33.05%
#4 Pons Pons +29.98%
#5 TENDIES TENDIES +21.40%
#6 龙虾 (Lobster) 龙虾 (Lobster) +20.56%
#7 o1.exchange o1.exchange +18.98%
#8 Giggle Fund Giggle Fund +18.51%
#9 Main Street Yield Main Street Yield +17.48%
#10 CZ'S Dog CZ'S Dog +16.11%
Coin of the day
GEKKO GEKKO
Settings
Language
ENGLISH
Currency
USD
Theme
Hubei Biocause Pharmaceutical Co., Ltd. Hubei Biocause Pharmaceutical Co., Ltd.

Hubei Biocause Pharmaceutical Co., Ltd.

000627
Rank in Stocks #9082
Hubei Biocause Pharmaceutical Co., Ltd., based in Jingmen, China, operates a... Hubei Biocause Pharmaceutical Co., Ltd., based in Jingmen, China, operates a multifaceted business. Its primary activities within China involve the provision of life and motor insurance policies. Additionally, the company is engaged in the pharmaceutical, chemical, and new energy fuel industries. Specifically, in the pharmaceutical field, it conducts contract research, development, and manufacturing of active pharmaceutical ingredients (APIs), intermediate compounds, and various drug forms such as tablets, granules, and capsules. Its chemical offerings include substances like dimethyl ether gas and a-chloropropionyl chloride. The firm also boasts an international presence, distributing its products to markets including the United States, the European Union, and other global locations.
Share Price
$0.2219522
Last synced: 2025-09-11
Market Cap
$1.10B
Change (1 day)
0.04%
Change (1 year)
0.17%
Country
CN
Trade Hubei Biocause Pharmaceutical Co., Ltd. (000627)

Category

Financial Services
P/S ratio for Hubei Biocause Pharmaceutical Co., Ltd. (000627)
P/S ratio as of August 2026 TTM: 0.16
According to Hubei Biocause Pharmaceutical Co., Ltd. latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.16. At the end of 2022 the company had a P/S ratio of 0.31.
P/S ratio history for Hubei Biocause Pharmaceutical Co., Ltd. from 2000 to 2026
P/S ratio at the end of each year
Year P/S Ratio Change
2026 (TTM) 0.16 -44.32%
2023 0.28 -9.91%
2022 0.31 -4.58%
2021 0.33 -40.28%
2020 0.55 -20.19%
2019 0.69 -22.30%
2018 0.89 32.65%
2017 0.67 -63.11%
2016 1.82 -93.34%
2015 27.32 249.63%
2014 7.81 114.32%
2013 3.65 -23.01%
2012 4.73 38.93%
2011 3.41 -36.39%
2010 5.36 1.98%
2009 5.25 133.47%
2008 2.25 -70.72%
2007 7.69 165.80%
2006 2.89 172.12%
2005 1.06 -63.15%
2004 2.88 -20.44%
2003 3.62 -72.89%
2002 13.37 64.55%
2001 8.12 4.25%
2000 7.79 0.00%
P/S ratio for similar companies or competitors
Company P/S Ratio P/S Ratio Difference Country
China Life Insurance Company Limited China Life Insurance Company Limited
China Life Insurance Company Limited
601628.SS
2.00 1,183.26%
CN
AIA Group Limited AIA Group Limited
AIA Group Limited
1299.HK
3.05 1,856.45%
HK
Manulife Financial Corporation Manulife Financial Corporation
Manulife Financial Corporation
MFC.TO
- -
CA
Fubon Financial Holding Co., Ltd. Fubon Financial Holding Co., Ltd.
Fubon Financial Holding Co., Ltd.
2881.TW
- -
TW
MetLife, Inc. MetLife, Inc.
MetLife, Inc.
MET.US
- -
US